1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Infarct in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study concluded that the typical gel formulation (liposomal Fasudil dispersed in hydroxypropyl methylcellulose solution, which is added to blank poloxamer 407) had been shown to have significantly anti-anginal properties, including easy administration, its application on the infarct area percentage and subsequently its pharmacological effect on the cardiac tissue." | 4.31 | Study on development and tissue permeation of different formulations of Fasudil. ( Alanazi, MG; Alshammari, AH; Alshammari, HS; Bandar, N; Elamine, BA; Gangireddy, R; Jandrajupalli, SB; Khalifa, NE; Khojali, WMA; Mohamed, OA; Osman, ME; Unnisa, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Unnisa, A | 1 |
| Khalifa, NE | 1 |
| Khojali, WMA | 1 |
| Osman, ME | 1 |
| Alshammari, AH | 1 |
| Alshammari, HS | 1 |
| Alanazi, MG | 1 |
| Bandar, N | 1 |
| Jandrajupalli, SB | 1 |
| Elamine, BA | 1 |
| Mohamed, OA | 1 |
| Gangireddy, R | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Infarct
| Article | Year |
|---|---|
Study on development and tissue permeation of different formulations of Fasudil.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Infarction; Liposomes; Rats; Rats, Sprague-D | 2023 |